Literature DB >> 35857066

T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis.

Temel Tirkes1, Anil K Dasyam2, Zarine K Shah3, Evan L Fogel4, Santhi Swaroop Vege5, Liang Li6, Shuang Li6, Stephanie T Chang7, Carlos A Farinas8, Joseph R Grajo9, Kareem Mawad10, Naoki Takahashi11, Sudhakar K Venkatesh11, Ashley Wachsman12, William E Fisher13, Christopher E Forsmark14, Phil A Hart15, Stephen J Pandol16, Walter G Park17, Stephen K Van Den Eeden18, Yunlong Yang6, Mark Topazian19, Dana K Andersen20, Jose Serrano20, Darwin L Conwell21, Dhiraj Yadav22.   

Abstract

PURPOSE: Our purpose was to validate the T1 SIR (T1 score) as an imaging biomarker for the staging of CP in a large, multi-institutional, prospective study.
METHODS: The prospective study population included 820 participants enrolled in the PROCEED study from nine clinical centers between June 2017 and December 2021. A radiologist at each institution used a standardized method to measure the T1 signal intensity of the pancreas and the reference organs (spleen, paraspinal muscle, liver), which was used to derive respective T1 scores. Participants were stratified according to the seven mechanistic stages of chronic pancreatitis (MSCP 0-6) based on their clinical history, MRCP, and CT findings.
RESULTS: The mean pancreas-to-spleen T1 score was 1.30 in participants with chronic abdominal pain, 1.22 in those with acute or recurrent acute pancreatitis, and 1.03 in definite CP. After adjusting for covariates, we observed a linear, progressive decline in the pancreas-to-spleen T1 score with increasing MSCP from 0 to 6. The mean pancreas-to-spleen T1 scores were 1.34 (MSCP 0), 1.27 (MSCP 1), 1.21 (MSCP 2), 1.16 (MSCP 3), 1.18 (MSCP 4), 1.12 (MSCP 5), and 1.05 (MSCP 6) (p < 0.0001). The pancreas-to-liver and pancreas-to-muscle T1 scores showed less linear trends and wider confidence intervals.
CONCLUSION: The T1 score calculated by SIR of the pancreas-to-spleen shows a negative linear correlation with the progression of chronic pancreatitis. It holds promise as a practical imaging biomarker in evaluating disease severity in clinical research and practice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  MRI; Mechanistic Stages of Chronic Pancreatitis; T1 score

Mesh:

Substances:

Year:  2022        PMID: 35857066     DOI: 10.1007/s00261-022-03611-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  33 in total

1.  Progression of parenchymal and ductal findings in patients with chronic pancreatitis: A 4-year follow-up MRI study.

Authors:  Emilie Steinkohl; Søren Schou Olesen; Esben Bolvig Mark; Tine Maria Hansen; Louise Kuhlmann Frandsen; Asbjørn Mohr Drewes; Jens Brøndum Frøkjær
Journal:  Eur J Radiol       Date:  2020-02-07       Impact factor: 3.528

2.  Guidelines for the Diagnostic Cross Sectional Imaging and Severity Scoring of Chronic Pancreatitis.

Authors:  Jens Brøndum Frøkjær; Fatih Akisik; Ammad Farooq; Burcu Akpinar; Anil Dasyam; Asbjørn Mohr Drewes; Ingfrid S Haldorsen; Giovanni Morana; John P Neoptolemos; Søren Schou Olesen; Maria Chiara Petrone; Andrea Sheel; Tooru Shimosoegawa; David C Whitcomb
Journal:  Pancreatology       Date:  2018-08-28       Impact factor: 3.996

3.  ACG Clinical Guideline: Chronic Pancreatitis.

Authors:  Timothy B Gardner; Douglas G Adler; Chris E Forsmark; Bryan G Sauer; Jason R Taylor; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2020-03       Impact factor: 10.864

4.  Is Cambridge scoring in chronic pancreatitis the same using ERCP and MRCP?: A need for revision of standards.

Authors:  Jordan Swensson; Fatih Akisik; David Collins; Søren Schou Olesen; Asbjørn Mohr Drewes; Jens Brøndum Frøkjær
Journal:  Abdom Radiol (NY)       Date:  2020-08-01

5.  Classification of pancreatitis.

Authors:  M Sarner; P B Cotton
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

6.  American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines.

Authors:  Darwin L Conwell; Linda S Lee; Dhiraj Yadav; Daniel S Longnecker; Frank H Miller; Koenraad J Mortele; Michael J Levy; Richard Kwon; John G Lieb; Tyler Stevens; Phillip P Toskes; Timothy B Gardner; Andres Gelrud; Bechien U Wu; Christopher E Forsmark; Santhi S Vege
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

Review 7.  Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments.

Authors:  Tyler Stevens; Darwin L Conwell; Gregory Zuccaro
Journal:  Am J Gastroenterol       Date:  2004-11       Impact factor: 10.864

8.  Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.

Authors:  Vinicius P V Alves; Samuel Brady; Nadeen Abu Ata; Yinan Li; Joseph MacLean; Bin Zhang; Susan E Sharp; Andrew T Trout
Journal:  AJR Am J Roentgenol       Date:  2022-09-21       Impact factor: 6.582

9.  Inter-observer variability of radiologists for Cambridge classification of chronic pancreatitis using CT and MRCP: results from a large multi-center study.

Authors:  Temel Tirkes; Zarine K Shah; Naoki Takahashi; Joseph R Grajo; Stephanie T Chang; Ashley M Wachsman; Kareem Mawad; Carlos A Farinas; Liang Li; Savitri N Appana; Darwin L Conwell; Dhiraj Yadav; Anil K Dasyam
Journal:  Abdom Radiol (NY)       Date:  2020-05

10.  Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Authors:  Temel Tirkes; Zarine K Shah; Naoki Takahashi; Joseph R Grajo; Stephanie T Chang; Sudhakar K Venkatesh; Darwin L Conwell; Evan L Fogel; Walter Park; Mark Topazian; Dhiraj Yadav; Anil K Dasyam
Journal:  Radiology       Date:  2018-10-16       Impact factor: 29.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.